Growing community of inventors

Morristown, NJ, United States of America

Meghan E Casey

Average Co-Inventor Count = 6.19

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 47

Meghan E CaseyShawn M Lawrence (16 patents)Meghan E CaseyAmy S Johnson (16 patents)Meghan E CaseyShunhai Wang (12 patents)Meghan E CaseyNing Li (12 patents)Meghan E CaseyJaimie Grapel (9 patents)Meghan E CaseyHunter Chen (8 patents)Meghan E CaseyAmardeep Singh Bhupender Bhalla (8 patents)Meghan E CaseyShadia Abike Oshodi (4 patents)Meghan E CaseyJaimie Mastrogiacomo (3 patents)Meghan E CaseyThomas Daly (1 patent)Meghan E CaseyErica Pyles (1 patent)Meghan E CaseyAndrew Tustian (1 patent)Meghan E CaseyNisha Palackal (1 patent)Meghan E CaseyAnkit Vartak (1 patent)Meghan E CaseyMatthew Franklin (1 patent)Meghan E CaseyShawn Lawrence (1 patent)Meghan E CaseyShadia Oshodi (1 patent)Meghan E CaseyMeghan E Casey (16 patents)Shawn M LawrenceShawn M Lawrence (25 patents)Amy S JohnsonAmy S Johnson (23 patents)Shunhai WangShunhai Wang (58 patents)Ning LiNing Li (53 patents)Jaimie GrapelJaimie Grapel (9 patents)Hunter ChenHunter Chen (23 patents)Amardeep Singh Bhupender BhallaAmardeep Singh Bhupender Bhalla (20 patents)Shadia Abike OshodiShadia Abike Oshodi (7 patents)Jaimie MastrogiacomoJaimie Mastrogiacomo (3 patents)Thomas DalyThomas Daly (30 patents)Erica PylesErica Pyles (24 patents)Andrew TustianAndrew Tustian (19 patents)Nisha PalackalNisha Palackal (16 patents)Ankit VartakAnkit Vartak (15 patents)Matthew FranklinMatthew Franklin (9 patents)Shawn LawrenceShawn Lawrence (3 patents)Shadia OshodiShadia Oshodi (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Regeneron Pharmaceuticals, Inc. (13 from 1,342 patents)

2. Regeneran Pharmaceuticals, Inc. (3 from 49 patents)


16 patents:

1. 12359165 - Taurine supplemented cell culture medium and methods of use

2. 12338274 - Anti-VEGF protein compositions and methods for producing the same

3. 12319728 - Anti-VEGF protein compositions and methods for producing the same

4. 12221619 - Taurine supplemented cell culture medium and methods of use

5. 12012445 - Anti-VEGF protein compositions and methods for producing the same

6. 12012444 - Anti-VEGF protein compositions and methods for producing the same

7. 11958894 - Anti-VEGF protein compositions and methods for producing the same

8. 11753459 - Anti-VEGF protein compositions and methods for producing the same

9. 11732025 - Anti-VEGF protein compositions and methods for producing the same

10. 11548932 - Anti-VEGF protein compositions and methods for producing the same

11. 11535663 - Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

12. 11505594 - Anti-VEGF protein compositions and methods for producing the same

13. 11472861 - Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

14. 11312936 - Taurine supplemented cell culture medium and methods of use

15. 11104715 - Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…